Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Near-patient testing shows potential, needs funding - BIVDA (British In Vitro Diagnostics Association)

This article was originally published in Clinica

Executive Summary

Hospital labs should not be funded like the laundry." This was the hard-hitting message from the British In Vitro Diagnostics Association's (BIVDA) conference, "Diagnostics - the best kept secret in healthcare", held last week in London. BIVDA spoke of the "huge potential benefits" of widening public access to diagnostic technology. BIVDA's calls were backed by the UK Patients' Association and the European Diagnostic Manufacturers Association (EDMA).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074106

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel